This webinar will discuss important new guideline updates regarding diagnosis and treatment optimisation for people with heart failure with reduced ejection fraction (HFrEF), including the role that sodium-glucose transport 2 inhibitors (SGLT2i) play in first-line management.
Recommendations have been rapidly changing in this area, including management implications for GPs. Join Dr Chee Khoo as he takes a practical, contemporary look at early diagnosis, treatment and management of people with HFrEF.
Professional development: 3 RACGP CPD points/1.5 ACRRM PDP hours